Biology of Neoplasm 2 Flashcards
inducers of apoptosis
injury
withdrawal of growth hormones
receptor ligand interactions
t cells
examples: chrmo, X-rays, hypoxia, genetic damage, growth factor/cytokine withdrawal, loss of cohesion/adhesion
substrates for the caspase cascade
cytoskeleton and DNA
how does the apoptosis go wrong?
dysregulation of anti-apoptotic signals (Bcl-2)
loss of pro apoptotic signals
mutations in these pathways result in resistance to chemotherapy and radiotherapy
mutated p53 is more difficult to treat
limitless replicative potential
usually cells stop growing- senescence- after a certain number of doubling
can be circumvented via disabling Rb and p53
immortalization- can multiply endlessly
telomeres
brackets of several thousand repeats on chromosomes that shorten w/ every replication cycle
attributed to inability of DNA polymerase to completely replicate of 3’ end
erosion of telomeres causes them to fuse end-to-end- signal that “time is up”
telomerase
creates telomeres
not present in normal cells
most cancers have it overexpressed
angiogenesis
blood supply necessary above 1mm size
dependent on ratio of VGEF to anti-angiogenetic agens
angiogenic switch- switch of ratio to pro angiogenesis
VGEF inhibitors
treatments utilize VGEF inhibitors to prevent angiogenesis
metastasis
millions are shed, but fewer than 1/10000 cells survive
steps include: dyscohesion matrix degradation motility adherence extravasation angiogenesis/proliferation
cadherins and integrins
loss of cadherins (cell to cell junctions) associated w/ increased metastatic potential
loss of integrins or integrin swithcing removes tumor cells from basement membrane and their preference is for ECM
matrix degradation
proteolytic enzymes- metalloproteases and collegenase to degrade membrane
soil and seed hypothesis
distant site may have a receptor or binding site on the surface of the tumor that acts as a homing mechanisms
helps explain why cancers have patterns of metastasis
therapeutic targets for metastasis
anti adhesive agents
martix metalloproteinase inhibitors
anti motility agents
ideal drug target
drives tumor growth turns on key mechanisms of cancer progression reversible dispensable measureable